Woodley Farra Manion Portfolio Management Inc. Has $49.91 Million Holdings in Danaher Corporation (NYSE:DHR)

Woodley Farra Manion Portfolio Management Inc. increased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 3.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 243,080 shares of the conglomerate's stock after purchasing an additional 8,893 shares during the quarter. Danaher makes up 2.5% of Woodley Farra Manion Portfolio Management Inc.'s holdings, making the stock its 19th largest position. Woodley Farra Manion Portfolio Management Inc.'s holdings in Danaher were worth $49,906,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth about $27,000. Sierra Ocean LLC boosted its position in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher during the 1st quarter worth approximately $31,000. Finally, Hurley Capital LLC acquired a new stake in Danaher during the 4th quarter valued at approximately $34,000. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

NYSE:DHR traded down $2.61 during mid-day trading on Wednesday, hitting $204.24. 5,692,474 shares of the company's stock traded hands, compared to its average volume of 4,032,979. The company has a market cap of $146.25 billion, a PE ratio of 43.46, a price-to-earnings-growth ratio of 2.87 and a beta of 0.77. The firm's 50 day simple moving average is $196.69 and its 200 day simple moving average is $203.24. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the company earned $1.72 EPS. The firm's quarterly revenue was up 3.4% on a year-over-year basis. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Friday, June 27th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Insider Buying and Selling

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have commented on DHR shares. Wells Fargo & Company dropped their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. TD Cowen lifted their price target on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research report on Wednesday, April 23rd. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research note on Friday, July 11th. Barclays restated an "overweight" rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.